Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Roche has expanded the Global Access Program, originally established to increase availability of HIV diagnostics in underserved countries, to include diagnostic tests for tuberculosis, hepatitis, and human papillomavirus (HPV). Increased access to reliable diagnostics will allow early, possibly life-saving, detection and decrease the spread of these diseases.
Roche launched the program in 2014 and began offering the added tests in July. The molecular diagnostics available include tests for determination of HIV-1 viral load, early diagnosis of HIV-1 and -2 in young infants, Mycobacterium tuberculosis (MTB) and rifampin/ison...
Source: MDDI - August 9, 2019 Category: Medical Devices Authors: Jenevieve Blair Polin Tags: IVD Source Type: news
Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus
Roche announced today the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle income country programs where the disease burden is the highest. (Source: Roche Investor Update)
Source: Roche Investor Update - July 22, 2019 Category: Pharmaceuticals Source Type: news
Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus
Roche announced today the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle income country programs where the disease burden is the highest. (Source: Roche Media News)
Source: Roche Media News - July 22, 2019 Category: Pharmaceuticals Source Type: news
Could Myriad ’s New Study Results Be Game Changers For Cancer Patients?
The 2019 American Society of Clinical Oncology’s meeting might be in the books, but the impact of some of the data released at the conference are certain to have implications for cancer patients for years to come.
Myriad Genetics presented data from several studies at ASCO that will no doubt have a long-lasting impact on cancer detection and treatment. The Salt Lake City, UT-based company spoke with MD+DI during ASCO about results from both colorectal cancer and breast cancer studies.
Some of the most talked-about results came from the Phase III POLO Study, which looked at how well the BRACAnalysis CDx id...
Source: MDDI - June 4, 2019 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news
Some Cervical Cancer Screening Strategies More Cost-Effective
TUESDAY, May 14, 2019 -- A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk human papillomavirus (hrHPV) testing... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 14, 2019 Category: Pharmaceuticals Source Type: news
The 4 Types of Doctors Visits You Should Make For a Long, Healthy Life
Prevention is often called the best medicine — but research has shown that millions of Americans are not getting the preventive care they should to live long, healthy lives. Obstacles like inadequate access to care and financial barriers can keep people away from the doctor, but anxiety and feeling like care is unnecessary are also common deterrents.
“There are a lot of things that every person could do to stay healthy, and this could help people to feel better, improve their quality of life and help them to live longer,” says Dr. Alex Krist, a professor of family medicine at Virginia Commonwealth Univer...
Source: TIME: Health - May 10, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Longevity public health Source Type: news
DNA test is an effective cervical cancer screening tool for women in low-income countries
(Dartmouth-Hitchcock Medical Center) Dartmouth researchers have introduced an inexpensive DNA-based test for human papillomavirus (HPV), the cause of cervical cancer, in Honduras. The test aid can effectively be used to screen women who have never been screened for this deadly disease. Results of the initiative revealed not only high positivity rates of HPV but unexpected differences in the types of HPV compared to those found in the US. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2019 Category: International Medicine & Public Health Source Type: news
DNA Test Is an Effective Cervical Cancer Screening Tool for Women in Low-Income Countries
Effective cervical cancer screening initiative by Dartmouth researchers in Honduras identifies different human papillomavirus types than those in the U.S. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 2, 2019 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Research cancer cervical cancer Gregory Tsongalis HPV Norris Cotton Cancer Center Source Type: news
The Germiest Place in Your Bathroom Isn ’t Your Toilet
Have you hovered over a toilet seat in a public restroom, desperate not to touch it?
Chances are good that you have. Americans are so grossed out by the thought of touching things in public bathrooms that 64% of people who use them flush the toilet with their feet, according to a 2013 survey, and 60% use paper towels to open bathroom doors. Several studies over the years have revealed that scary-sounding bacteria and viruses cover the surfaces of bathrooms.
But there’s a lot you don’t know about the germs that lurk in the bathroom. Here are four surprising facts about the germs you encounter in restrooms at an...
Source: TIME: Health - April 25, 2019 Category: Consumer Health News Authors: Julissa Treviño Tags: Uncategorized public health Source Type: news
Cervical cancer subtype rising in some sub-populations
(American Cancer Society) A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus (HPV) testing and vaccination (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news
Sexually transmitted infections are on the rise. Here ’s what you need to know to protect yourself
UCLA Health Rates of sexually transmitted diseases have risen for the past four years to record highs in the United States, according to the Centers for Disease Control and Prevention ’slatest analysis. In California, the state health departmentfound that the number of people diagnosed with syphilis, gonorrhea or chlamydia in 2017 was 45 percent higher than five years prior.These sorts of statistics may spark a fear that there ’s little we can do to protect ourselves — but that’s not the full story.Dr. Leena Nathan, an obstetrician/gynecologist at UCLA Health-Westlake Village, consults with people daily about sexu...
Source: UCLA Newsroom: Health Sciences - February 14, 2019 Category: Universities & Medical Training Source Type: news
New Study Finds Discrepancies in Cervical Cancer Screening Rates
A new Mayo Clinic study shows that the percentage of women who are screened for cervical cancer could be far lower than national data suggests. The researchers' findings were published in the Journal of Women’s Health and show that less than two thirds of women ages 30 to 65 were up-to-date with cervical cancer screenings in 2016.
What’s telling is the percentage is even lower for women ages 21 to 29, with just over half current on screenings. Mayo Clinic Researchers said those figures are well below the 81% screening compliance rate that was self-reported in the 2015 National Health Int...
Source: MDDI - January 7, 2019 Category: Medical Devices Authors: MDDI Staff Tags: IVD Testing Source Type: news
New epigenetic cervical cancer test has 100 per cent detection rate
(Queen Mary University of London) A new test for cervical cancer was found to detect all of the cancers in a trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study by Queen Mary University of London. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 17, 2018 Category: Cancer & Oncology Source Type: news
Mail-Based HPV Testing May Increase Access
TUESDAY, Dec. 11, 2018 -- A mail-based human papillomavirus (HPV) self-testing program appears to be a promising approach to screening women in Appalachia, according to a pilot study published online Nov. 19 in Sexually Transmitted Diseases.
Paul L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2018 Category: Pharmaceuticals Source Type: news
Increased cervical cancer risk in women with positive HPV, but no cellular abnormalities
(Wiley) Researchers have uncovered an increased risk of cervical cancer in women whose cervical cells test positive for certain high-risk human papillomavirus (HPV) types but do not show any signs of cellular abnormalities. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may help refine guidelines for cervical cancer screening. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2018 Category: Cancer & Oncology Source Type: news
